- Home
- UGRO vs SXTP Comparison
UGRO vs SXTP Comparison
Compare UGRO & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UGRO | SXTP |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0M | 2.9M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | UGRO | SXTP |
|---|---|---|
| Price | $0.18 | $4.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $3.00 | ★ $17.60 |
| AVG Volume (30 Days) | 610.7K | ★ 10.1M |
| Earning Date | 02-17-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $40,008,850.00 | $1,364,945.00 |
| Revenue This Year | $98.41 | $146.28 |
| Revenue Next Year | $23.34 | $24.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 202.10 |
| 52 Week Low | $0.17 | $1.36 |
| 52 Week High | $1.12 | $24.00 |
Technical Indicators
Market Signals| Indicator | UGRO | SXTP |
|---|---|---|
| Relative Strength Index (RSI) | 27.26 | 85.16 |
| Support Level | $0.23 | $1.86 |
| Resistance Level | $0.22 | $8.62 |
| Average True Range (ATR) | 0.02 | 0.48 |
| MACD | -0.01 | 0.48 |
| Stochastic Oscillator | 7.18 | 51.21 |
Price Performance
Historical ComparisonAbout UGRO urban-gro Inc.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.